Nonpartisan civic infrastructure
AllCiv·Legis1
·

H.R. 3840

BillFederalHouseIn Committee
To amend the Public Health Service Act to authorize certain contracts and cooperative agreements with clinical laboratories for purposes of delivery of medical products to the Strategic National Stockpile.
About This Bill
Committee
Latest Action · June 9, 2023
Referred to the Subcommittee on Health.
Congress
118th (2023–2025)
Introduced
June 6, 2023
Cosponsors (1)
1D 0R
View PDF ↗

Summary

Highlight any text to annotate
Ensuring Sufficient Supply of Testing Act This bill expressly authorizes the Department of Health and Human Services (HHS) to enter into certain contracts and cooperative agreements with clinical laboratories as part of maintaining the Strategic National Stockpile. The Strategic National Stockpile consists of drugs, vaccines, medical products, and other supplies that may be deployed to respond to bioterrorist attacks or other public health emergencies. Current law permits HHS to enter into specified types of contracts and cooperative agreements with vendors (e.g., manufacturers and distributors of medical products) for managing inventory of and ensuring production capacity for supplies needed for the stockpile. The bill specifies that clinical laboratories may participate as vendors in those types of contracts and agreements.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.